Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.35M Sell
14,286
-35,714
-71% -$4.92M 5.64% 6
2026
Q1
$6.99M Buy
50,000
+23,672
+90% +$4.31M 9.59% 3
2025
Q4
$4.72M Sell
26,328
-48,672
-65% -$8.32M 9.91% 3
2025
Q3
$15.2M Buy
75,000
+60,000
+400% +$13M 6.96% 5
2025
Q2
$2.84M Sell
15,000
-32,500
-68% -$6.04M 3.32% 11
2025
Q1
$11.1M Buy
+47,500
New +$16.4M 9.27% 2

Other funds holding RH

Baypointe Partners's RH Position: Q2 2026 in Review

Baypointe Partners reduced its RH (RH) stake by 71% in Q2 2026, selling an estimated $4.92M and leaving 14,286 shares worth $2.35M. The position accounts for 5.64% of the portfolio, ranked #6.

Baypointe Partners first reported a position in RH in Q1 2025 and has held it in 6 quarters since. The position peaked at $15.2M in Q3 2025. 370 funds tracked by Wall St. Rank hold RH as of Q2 2026.

  • Baypointe Partners held 14,286 shares of RH worth $2.35M as of Q2 2026.
  • Baypointe Partners sold 35,714 RH shares in Q2 2026, an estimated $4.92M.
  • RH made up 5.64% of Baypointe Partners's portfolio in Q2 2026, its #6 holding.
  • Baypointe Partners first reported a position in RH in Q1 2025 and has held it in 6 quarters since.
  • Baypointe Partners's RH position peaked at $15.2M in Q3 2025.
  • 370 funds tracked by Wall St. Rank held RH as of Q2 2026.

Based on Baypointe Partners's 13F filing for Q2 2026, filed 30 Jul 2026.